Nitric oxide, the new architect of epigenetic landscapes

被引:46
作者
Vasudevan, Divya [1 ]
Bovee, Rhea C. [2 ]
Thomas, Douglas D. [2 ]
机构
[1] Weill Cornell Med Coll, Dept Urol, New York, NY 10021 USA
[2] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA
来源
NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 2016年 / 59卷
基金
美国国家卫生研究院;
关键词
Nitric oxide; Epigenetics; Histone posttranslational modifications; DNA methylation; microRNA; Cancer; CHEMICAL BIOLOGY; INDUCIBLE FACTOR-1-ALPHA; HISTONE METHYLATION; GUANYLYL-CYCLASE; DNA METHYLATION; S-NITROSYLATION; TUMOR-GROWTH; CANCER; CHROMATIN; NO;
D O I
10.1016/j.niox.2016.08.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitric oxide ((NO)-N-center dot) is an endogenously produced signaling molecule with multiple regulatory functions in physiology and disease. The most studied molecular mechanisms underlying the biological functions of (NO)-N-center dot include its reaction with heme proteins and regulation of protein activity via modification of thiol residues. A significant number of transcriptional responses and phenotypes observed in (NO)-N-center dot microenvironments, however, still lack mechanistic understanding. Recent studies shed new light on (NO)-N-center dot signaling by revealing its influence on epigenetic changes within the cell. Epigenetic alterations are important determinants of transcriptional responses and cell phenotypes, which can relay heritable information during cell division. As transcription across the genome is highly sensitive to these upstream epigenetic changes, this mode of (NO)-N-center dot signaling provides an alternate explanation for (NO)-N-center dot-mediated gene expression changes and phenotypes. This review will provide an overview of the interplay between (NO)-N-center dot and epigenetics as well as emphasize the unprecedented importance of these pathways to explain phenotypic effects associated with biological (NO)-N-center dot synthesis. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:54 / 62
页数:9
相关论文
共 102 条
[1]   Epigenetics, the holy grail in the pathogenesis of systemic sclerosis [J].
Altorok, Nezam ;
Almeshal, Nawaf ;
Wang, Yongqing ;
Kahaleh, Bashar .
RHEUMATOLOGY, 2015, 54 (10) :1759-1770
[2]   Nitric Oxide-Mediated Histone Hyperacetylation in Oral Cancer: Target for a Water-Soluble HAT Inhibitor, CTK7A [J].
Arif, Mohammed ;
Vedamurthy, Bhusainahalli M. ;
Choudhari, Ramesh ;
Ostwal, Yogesh B. ;
Mantelingu, Kempegowda ;
Kodaganur, Gopinath S. ;
Kundu, Tapas K. .
CHEMISTRY & BIOLOGY, 2010, 17 (08) :903-913
[3]  
Barski A., CELL, P129
[4]   APPARENT HYDROXYL RADICAL PRODUCTION BY PEROXYNITRITE - IMPLICATIONS FOR ENDOTHELIAL INJURY FROM NITRIC-OXIDE AND SUPEROXIDE [J].
BECKMAN, JS ;
BECKMAN, TW ;
CHEN, J ;
MARSHALL, PA ;
FREEMAN, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1620-1624
[5]   On the activation of soluble guanylyl cyclase by nitric oxide [J].
Bellamy, TC ;
Wood, J ;
Garthwaite, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :507-510
[6]   Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry [J].
Berdasco, Maria ;
Esteller, Manel .
DEVELOPMENTAL CELL, 2010, 19 (05) :698-711
[7]   Nitric Oxide and Histone Acetylation-Shaping Craniofacial Development [J].
Berghella, Libera ;
Puri, Pier Lorenzo .
CHEMISTRY & BIOLOGY, 2014, 21 (05) :565-566
[8]   Synthesis and Biological Evaluation of the First Example of NO-Donor Histone Deacetylase Inhibitor [J].
Borretto, Emily ;
Lazzarato, Loretta ;
Spallotta, Francesco ;
Cencioni, Chiara ;
D'Alessandra, Yuri ;
Gaetano, Carlo ;
Fruttero, Roberta ;
Gasco, Alberto .
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (10) :994-999
[9]   Uncovering the role of 5-hydroxymethylcytosine in the epigenome [J].
Branco, Miguel R. ;
Ficz, Gabriella ;
Reik, Wolf .
NATURE REVIEWS GENETICS, 2012, 13 (01) :7-13
[10]   The Chemical Biology of S-Nitrosothiols [J].
Broniowska, Katarzyna A. ;
Hogg, Neil .
ANTIOXIDANTS & REDOX SIGNALING, 2012, 17 (07) :969-980